Business Description
Ensign Group Inc
NAICS : 623110
SIC : 8051
ISIN : US29358P1012
Share Class Description:
ENSG: Ordinary SharesTotal Employee Number:
46,000Compare
Compare
Traded in other countries / regions
ENSG.USAEGB.Germany1ENSG.Italy Index Membership
Russell 2000Russell 3000 IPO Date
2007-11-09Description
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.27 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.95 | |||||
Debt-to-EBITDA | 3.78 | |||||
Interest Coverage | 56.93 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 3.51 | |||||
Beneish M-Score | -2.61 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17.3 | |||||
3-Year EBITDA Growth Rate | 15 | |||||
3-Year EPS without NRI Growth Rate | 16.6 | |||||
3-Year FCF Growth Rate | 24.6 | |||||
3-Year Book Growth Rate | 19.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 11.45 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 11.5 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 73.11 | |||||
9-Day RSI | 58.46 | |||||
14-Day RSI | 50.72 | |||||
3-1 Month Momentum % | -15.27 | |||||
6-1 Month Momentum % | -2.67 | |||||
12-1 Month Momentum % | 11.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.56 | |||||
Quick Ratio | 1.56 | |||||
Cash Ratio | 0.7 | |||||
Days Sales Outstanding | 42.56 | |||||
Days Payable | 8.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.16 | |||||
Dividend Payout Ratio | 0.04 | |||||
3-Year Dividend Growth Rate | 4.3 | |||||
Forward Dividend Yield % | 0.16 | |||||
5-Year Yield-on-Cost % | 0.2 | |||||
3-Year Average Share Buyback Ratio | -1.4 | |||||
Shareholder Yield % | -1.58 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 15.91 | |||||
Operating Margin % | 8.51 | |||||
Net Margin % | 6.89 | |||||
EBITDA Margin % | 11.27 | |||||
FCF Margin % | 7.7 | |||||
OCF Margin % | 11.23 | |||||
ROE % | 17.04 | |||||
ROA % | 6.99 | |||||
ROIC % | 8.25 | |||||
3-Year ROIIC % | 5.82 | |||||
ROC (Joel Greenblatt) % | 13.37 | |||||
ROCE % | 11.05 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 26.72 | |||||
Forward PE Ratio | 21.71 | |||||
PE Ratio without NRI | 24.31 | |||||
Shiller PE Ratio | 45.2 | |||||
Price-to-Owner-Earnings | 20.45 | |||||
PEG Ratio | 1.84 | |||||
PS Ratio | 1.83 | |||||
PB Ratio | 4.05 | |||||
Price-to-Tangible-Book | 4.24 | |||||
Price-to-Free-Cash-Flow | 23.99 | |||||
Price-to-Operating-Cash-Flow | 16.32 | |||||
EV-to-EBIT | 23.16 | |||||
EV-to-Forward-EBIT | 18.61 | |||||
EV-to-EBITDA | 18.91 | |||||
EV-to-Forward-EBITDA | 13.08 | |||||
EV-to-Revenue | 2.13 | |||||
EV-to-Forward-Revenue | 1.88 | |||||
EV-to-FCF | 27.68 | |||||
Price-to-GF-Value | 0.93 | |||||
Price-to-Projected-FCF | 1.71 | |||||
Price-to-DCF (Earnings Based) | 0.78 | |||||
Price-to-DCF (FCF Based) | 2.08 | |||||
Price-to-Median-PS-Value | 1.11 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.82 | |||||
Price-to-Graham-Number | 2.14 | |||||
Earnings Yield (Greenblatt) % | 4.32 | |||||
FCF Yield % | 4.24 | |||||
Forward Rate of Return (Yacktman) % | 16 |
Ensign Group Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ensign Group Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-04 13:00 | In 133 days | ||
| Third quarter earnings results for 2026 | 2026-11-03 | In 131 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-24 13:00 | In 30 days | ||
| Second quarter earnings results for 2026 | 2026-07-24 | In 29 days | ||
| USD 0.065000 Cash Dividend | 2026-06-30 | In 5 days | ||
| General meeting for 2026 | 2026-05-13 10:00 | 176.04 (+2.62%) | ||
| First quarter earnings conference call for 2026 | 2026-05-01 13:00 | 186.69 (+0.67%) | ||
| First quarter earnings results for 2026 | 2026-04-30 | 186.40 (+0.53%) | ||
| USD 0.065000 Cash Dividend | 2026-03-31 | 200.41 (-0.11%) | ||
| Oppenheimer 36th Annual Healthcare MedTech & Services Conference | 2026-03-19 10:40 | 204.96 (-2.10%) |
Show
Entries
Guru Commentaries on NAS:ENSG
No articles.
Press Release
Articles on Ensign Group Inc
No articles.
Headlines
See More- 1
Jun 19, 2026
Ensign declares $0.065 dividend
Seeking Alpha • 6:52am
Jun 17, 2026
$ENSG Fraud Notice: BFA Law is Investigating Ensign for Securities Fraud over its Regulatory Issues – Investors with Losses Notified to Contact the Firm
Benzinga • 2:23pm
Jun 15, 2026
ENSG INVESTOR ALERT: Holzer & Holzer, LLC Investigation of The Ensign Group, Inc.
Benzinga • 10:39am
Jun 11, 2026
Ensign Group shares drop after Muddy Waters raises compliance concerns
Seeking Alpha • 1:21pm
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers